1. Exploration of a Novel Prognostic Risk Signature and Its Effect on the Immune Response in Nasopharyngeal Carcinoma
   Shuang Zhao et al, 2021, Frontiers in Oncology CrossRef
2. Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA Pathway
   Dongyang Gao et al, 2021, Journal of Oncology CrossRef
3. RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
   Sarah Bajan et al, 2020, Cells CrossRef
4. Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs
   Zhiguo Wang et al, 2022, Polypharmacology CrossRef
5. Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
   Arsinoe C. Thomaidou et al, 2022, International Journal of Molecular Sciences CrossRef
6. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
   Peter Shaw et al, 2021, Cancers CrossRef
7. A Five-MicroRNA Signature Predicts the Prognosis in Nasopharyngeal Carcinoma
   Shixiong Wu et al, 2021, Frontiers in Oncology CrossRef
8. Multimodality Management of EBV-Associated Nasopharyngeal Carcinoma
   Justin Yu et al, 2021, Cancers CrossRef
9. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
   Wanzhen Li et al, 2021, PeerJ CrossRef
10. Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma
    Jinhui Zhou et al, 2022, Frontiers in Oncology CrossRef
11. Construction and Analysis of lncRNA-Mediated ceRNA Network in Nasopharyngeal Carcinoma Based on Weighted Correlation Network Analysis
    Zhenning Zou et al, 2020, BioMed Research International CrossRef